Disease | dermatomyositis |
Symptom | C0206062|interstitial lung disease |
Sentences | 25 |
PubMedID- 23983712 | He was suspected of rapidly progressing interstitial lung disease with dermatomyositis and transferred to our hospital. |
PubMedID- 23400027 | Limitations to the 6-minute walk test in dermatomyositis with interstitial lung disease in comparison with idiopathic interstitial pneumonia. |
PubMedID- 26459323 | The objective of this study is to assess serum il8 and the potential activity of circulating neutrophils on relative messenger rna (mrna) levels and their relationship with disease activity in clinically amyopathic dermatomyositis (cadm) associated with interstitial lung disease (ild). |
PubMedID- 20506189 | Conclusion: these promising data indicate that mycophenolate mofetil may be a useful therapy for interstitial lung disease in patients with dermatomyositis, but larger studies are needed to more definitively evaluate the role of this medication in therapy. |
PubMedID- 23158422 | Objective: to explore the possible diagnostic values of serum surfactant protein-a (sp-a) and surfactant protein-d (sp-d) for interstitial lung diseases (ild) in patients with polymyositis or dermatomyositis (pm/dm). |
PubMedID- 25431723 | At the initial visit, clinically amyopathic dermatomyositis (cadm) with rapidly progressive interstitial lung disease (rp-ild) was suspected because he had progressive dyspnea but no muscle weakness. |
PubMedID- 26101728 | Incidence and impact of interstitial lung disease and malignancy in patients with polymyositis, dermatomyositis, and clinically amyopathic dermatomyositis: a retrospective cohort study. |
PubMedID- 22931947 | Objective: to explore the clinical and laboratory features and the prognosis of juvenile dermatomyositis (jdm) complicated with interstitial lung disease (ild). |
PubMedID- 20800454 | Serum tarc/ccl17 levels are increased in dermatomyositis associated with interstitial lung disease. |
PubMedID- 21532064 | Anti-cadm-140 antibody-positive juvenile dermatomyositis with rapidly progressive interstitial lung disease and cardiac involvement. |
PubMedID- 25698373 | A case of anti-mda5-positive rapidly progressive interstitial lung disease in a patient with clinically amyopathic dermatomyositis ameliorated by rituximab, in addition to standard immunosuppressive treatment. |
PubMedID- 24142786 | interstitial lung disease in patients with polymyositis and dermatomyositis--report of three cases. |
PubMedID- 25888887 | Serum progranulin levels are elevated in dermatomyositis patients with acute interstitial lung disease, predicting prognosis. |
PubMedID- 23569020 | Objective: : to study the clinical features of interstitial lung disease (ild) in patients with dermatomyositis and factors related to its development. |
PubMedID- 24252021 | Serum interleukin 6 levels as a useful prognostic predictor of clinically amyopathic dermatomyositis with rapidly progressive interstitial lung disease. |
PubMedID- 21748914 | Subsequently, a diagnosis of amyopathic dermatomyositis with interstitial lung disease and pneumomediastinum was made. |
PubMedID- 25433590 | interstitial lung disease-associated with amyopathic dermatomyositis and anti-mda5 autoantibodies. |
PubMedID- 26328651 | Rapidly progressive interstitial lung disease (ild) is associated with dermatomyositis (dm) and has a high mortality rate even with immunosuppressive agents. |
PubMedID- 24325117 | Objective: to investigate the clinical features and risk factors associated with interstitial lung disease (ild) in patients with classic dermatomyositis (classic dm) or clinical amyopathic dermatomyositis (cadm). |
PubMedID- 22325787 | Clinical factors to predict a poor prognosis and refractory disease in patients with polymyositis and dermatomyositis associated with interstitial lung disease. |
PubMedID- 23250474 | Autoantibodies against melanoma differentiation-associated gene 5 (mda5) are important serological markers in dermatomyositis (dm) with rapidly progressive interstitial lung disease (ild). |
PubMedID- 23423441 | This diagnosis should always come to mind in patients that present with signs of myositis, dermatomyositis, or polymyositis associated with interstitial lung disease. |
PubMedID- 22863719 | Pilot study of interleukin-27 in pathogenesis of dermatomyositis and polymyositis: associated with interstitial lung diseases. |
PubMedID- 22781896 | A clinical analysis of dermatomyositis with interstitial lung disease in 20 patients. |
PubMedID- 25622670 | Objective: to explore the clinical features and prognosis of dermatomyositis patients with interstitial lung disease (ild) as an initial manifestation. |
Page: 1